Announcements Trials
Browse Landscape

Status

Unknown 1Recruiting 1Completed 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 22Observational 3

Sponsor

Cancer Type

Breast 3Thoracic 1Gastrointestinal 1

Conditions

Breast Neoplasms 24Carcinoma, Non-Small-Cell Lung 15Colorectal Neoplasms 13Lung Neoplasms 12Neoplasms 11Stomach Neoplasms 9Neoplasm Metastasis 6Colonic Neoplasms 6Esophageal Neoplasms 5Small Cell Lung Carcinoma 4Pancreatic Neoplasms 4Leukemia, Myeloid, Acute 4Head and Neck Neoplasms 4Esophageal Squamous Cell Carcinoma 4Urinary Bladder Neoplasms 3Triple Negative Breast Neoplasms 3Sarcoma 3Ovarian Neoplasms 3Osteosarcoma 3Multiple Myeloma 3Melanoma 3Lymphoma, Follicular 3Lymphoma 3Waldenstrom Macroglobulinemia 2Vulvar Neoplasms 2Uterine Cervical Neoplasms 2Thymus Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Recurrence 2Rectal Neoplasms 2

Interventions

Blood Specimen Collection 5Drug Therapy 3Specimen Handling 2Immune Checkpoint Inhibitors 2Carboplatin 2Biopsy, Large-Core Needle 2Biopsy 2toripalimab 1tislelizumab 1taxane 1sacituzumab govitecan 1pembrolizumab 1atezolizumab 1Zoledronic Acid 1Urine Specimen Collection 1Prophylactic Mastectomy 1Paracentesis 1Neuropsychological Tests 1Mifepristone 1Medicine, Chinese Traditional 1Mastectomy, Segmental 1Magnetic Resonance Spectroscopy 1Interviews as Topic 1Immunotherapy 1Immunohistochemistry 1Gene Expression Profiling 1Doxorubicin 1DNA 1Cyclophosphamide 1Combined Modality Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Observational × Triple Negative Breast Neoplasms × Drug Therapy × Clear all
NCT04638751 2024-04-05

ARGONAUT: Stool and Blood Sample Bank for Cancer Patients

Persephone Biosciences

Unknown
5,000 enrolled
BreastGastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms, Triple Negative Breast Neoplasms

NCT05916755 2023-06-23

PORTRAIT

Vall d'Hebron Institute of Oncology

Recruiting
100 enrolled
Breast

Triple Negative Breast Neoplasms

NCT02247037 2020-07-07

Patient-derived Xenograft (PDX) Modeling of Treatment Response for Triple Negative Breast Cancer

Icahn School of Medicine at Mount Sinai

Completed
68 enrolled
Breast

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡